J. Hilger

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

C. Chen, J. Berenson, Eric Wirtschafter, 2011, British journal of haematology.

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

J. Berenson, O. Yellin, Y. Nassir, 2008, Annals of Hematology.

Phase 2 study of two sequential three‐drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma

S. Jagannath, D. Vesole, B. Durie, 2010, British journal of haematology.